Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Revere Pharmaceuticals Inc. See All Filings	D	2023-06-12 13:51:35 UTC
Amount To Be Raised $3,559,612 Associated Brokers / Dealers N/A CIK Number 0001778959 Filed Document 0001778959-23-000001 Exclusions or Exemptions 506b Accepted Date 2023-06-12 13:51:35 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Revere Pharmaceuticals Inc. See All Filings	D	2021-09-01 13:42:24 UTC
Amount To Be Raised $1,999,999 Associated Brokers / Dealers N/A CIK Number 0001778959 Filed Document 0001778959-21-000002 Exclusions or Exemptions 506b Accepted Date 2021-09-01 13:42:24 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Revere Pharmaceuticals Inc. See All Filings	D/A	2021-01-12 15:00:53 UTC
Amount To Be Raised $3,454,842 Associated Brokers / Dealers N/A CIK Number 0001778959 Filed Document 0001778959-21-000001 Exclusions or Exemptions 506b Accepted Date 2021-01-12 15:00:53 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Revere Pharmaceuticals Inc. See All Filings	D/A	2020-06-22 09:21:45 UTC
Amount To Be Raised $3,487,668 Associated Brokers / Dealers N/A CIK Number 0001778959 Filed Document 0001778959-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-06-22 09:21:45 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Revere Pharmaceuticals Inc. See All Filings	D	2019-06-21 08:39:05 UTC
Amount To Be Raised $1,923,915 Associated Brokers / Dealers N/A CIK Number 0001778959 Filed Document 0001778959-19-000001 Exclusions or Exemptions 506b Accepted Date 2019-06-21 08:39:05 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity